Jon Wigginton, President of Research and Development at Bright Peak Therapeutics, shared a post on LinkedIn:
“Latest update to the “Hallmarks of Cancer” published in Cell by Douglas Hanahan. Further evolution of this resilient conceptual framework.
Love using this framework in tandem with the ongoing iterations of the “The Cancer Immunity Cycle” by Ira Mellman and Dan Chen over the years and “The Hallmarks of Cancer Immune Evasion” from Galatti, et al in Cancer Cell (2024). Great way to conceptually organize the big picture regarding cancer and the interface between tumors and the host immune response.”
Title: Hallmarks of cancer-Then and now, and beyond
Author: Douglas Hanahan
Read The Full Article
More posts featuring Jon Wigginton on OncoDaily.